Logo image of PINK.CA

PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis

Canada - TSX-V:PINK - CA71385D1078 - Common Stock

0.24 CAD
0 (0%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PINK. PINK was compared to 16 industry peers in the Health Care Equipment & Supplies industry. The financial health of PINK is average, but there are quite some concerns on its profitability. PINK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PINK had negative earnings in the past year.
PINK had a negative operating cash flow in the past year.
PINK had negative earnings in each of the past 5 years.
PINK had a negative operating cash flow in each of the past 5 years.
PINK.CA Yearly Net Income VS EBIT VS OCF VS FCFPINK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -235.45%, PINK is in line with its industry, outperforming 43.75% of the companies in the same industry.
PINK has a Return On Equity (-361.48%) which is in line with its industry peers.
Industry RankSector Rank
ROA -235.45%
ROE -361.48%
ROIC N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
PINK.CA Yearly ROA, ROE, ROICPINK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 62.17%, PINK is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
In the last couple of years the Gross Margin of PINK has grown nicely.
The Profit Margin and Operating Margin are not available for PINK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
PINK.CA Yearly Profit, Operating, Gross MarginsPINK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K

More info and screens

4

2. Health

2.1 Basic Checks

PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PINK has more shares outstanding
The number of shares outstanding for PINK has been increased compared to 5 years ago.
The debt/assets ratio for PINK is higher compared to a year ago.
PINK.CA Yearly Shares OutstandingPINK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PINK.CA Yearly Total Debt VS Total AssetsPINK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -21.84, we must say that PINK is in the distress zone and has some risk of bankruptcy.
PINK has a Altman-Z score (-21.84) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.02 indicates that PINK is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.02, PINK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -21.84
ROIC/WACCN/A
WACC7.84%
PINK.CA Yearly LT Debt VS Equity VS FCFPINK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

PINK has a Current Ratio of 1.61. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
PINK has a better Current ratio (1.61) than 81.25% of its industry peers.
PINK has a Quick Ratio of 1.55. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
PINK has a better Quick ratio (1.55) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.55
PINK.CA Yearly Current Assets VS Current LiabilitesPINK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

PINK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.70%.
The Revenue has grown by 209.29% in the past year. This is a very strong growth!
The Revenue has been growing by 354.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-13.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.12%
Revenue 1Y (TTM)209.29%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%107.72%

3.2 Future

Based on estimates for the next years, PINK will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.59% on average per year.
PINK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 119.37% yearly.
EPS Next Y21.56%
EPS Next 2Y20.02%
EPS Next 3Y18.41%
EPS Next 5Y19.59%
Revenue Next Year269.92%
Revenue Next 2Y209.51%
Revenue Next 3Y171.19%
Revenue Next 5Y119.37%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PINK.CA Yearly Revenue VS EstimatesPINK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
PINK.CA Yearly EPS VS EstimatesPINK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PINK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PINK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PINK.CA Price Earnings VS Forward Price EarningsPINK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PINK.CA Per share dataPINK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PINK's earnings are expected to grow with 18.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.02%
EPS Next 3Y18.41%

More info and screens

0

5. Dividend

5.1 Amount

PINK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERIMETER MEDICAL IMAGING AI

TSX-V:PINK (10/17/2025, 7:00:00 PM)

0.24

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)11-12 2025-11-12
Inst Owners24.49%
Inst Owner ChangeN/A
Ins Owners13.68%
Ins Owner ChangeN/A
Market Cap28.51M
Analysts80
Price Target1.77 (637.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.65%
Min EPS beat(2)-18.81%
Max EPS beat(2)22.11%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)64.15%
Min Revenue beat(2)-32.1%
Max Revenue beat(2)160.4%
Revenue beat(4)3
Avg Revenue beat(4)33.24%
Min Revenue beat(4)-32.1%
Max Revenue beat(4)160.4%
Revenue beat(8)4
Avg Revenue beat(8)4.28%
Revenue beat(12)6
Avg Revenue beat(12)-0.89%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.09%
EPS NY rev (1m)7.25%
EPS NY rev (3m)30.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.04
P/FCF N/A
P/OCF N/A
P/B 4.51
P/tB 4.51
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.02
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -235.45%
ROE -361.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.17%
FCFM N/A
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score3
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 235.94%
Cap/Sales 123.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.55
Altman-Z -21.84
F-Score3
WACC7.84%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.12%
EPS Next Y21.56%
EPS Next 2Y20.02%
EPS Next 3Y18.41%
EPS Next 5Y19.59%
Revenue 1Y (TTM)209.29%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%107.72%
Revenue Next Year269.92%
Revenue Next 2Y209.51%
Revenue Next 3Y171.19%
Revenue Next 5Y119.37%
EBIT growth 1Y11.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.29%
EBIT Next 3Y15.32%
EBIT Next 5Y23.3%
FCF growth 1Y-50.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.5%
OCF growth 3YN/A
OCF growth 5YN/A